4D Molecular Therapeutics, Inc.FDMTNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending lower, above historical average.
Left:
||||
Price-to-book ratio
Latest
0.59
↑ 109% above average
Average (7y)
-6.41
Historical baseline
Range
High:4.31
Low:-30.67
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 0.59 | -77.2% |
| 2023 | 2.58 | -17.1% |
| 2022 | 3.11 | +62.9% |
| 2021 | 1.91 | -55.8% |
| 2020 | 4.31 | +129.3% |
| 2019 | -14.70 | +20.0% |
| 2018 | -18.38 | +40.1% |
| 2017 | -30.67 | - |